InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,157.22
(
0.57%
)
US TECH 100
17,491.60
(
0.42%
)
Dow Jones
38,725.15
(
0.13%
)
Brent Oil
83.11
(
-0.02%
)
Bitcoin
63,505.99
(
-0.77%
)
Post# of 38376
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

GM_FSJ

Send PM Follow Ignore
Followers 93
Posts 6268
Boards Moderated 0
Alias Born 03/17/2013

GM_FSJ

Re: sizzleweed post# 36154

Tuesday, 11/25/2014 8:50:25 AM

Tuesday, November 25, 2014 8:50:25 AM

Post# of 38376

SAN DIEGO, CA -- (Marketwired) -- 11/25/14 -- Regen BioPharma Inc. (OTCBB: RGBP) announced today acquisition of patent application # US 13/652,395 with a priority date of November 2008 which covers a novel gene target essential for the survival of cancer stem cells. Inventors of the intellectual property on which this patent application was filed are University of Toronto Hematologist Dr. Richard Wells and Dr. Christine Ichim, Senior Research Consultant for Regen BioPharma.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up